Particle.news

Download on the App Store

Germany’s Drug Regulator Warns Against Kratom Use Over Serious Health Risks

Germany’s drug authority flagged unverified health claims alongside evidence of organ damage in a review that could lead to formal restrictions

Image
Image
Image
Image

Overview

  • The Federal Institute for Drugs and Medical Devices formally advised against using Kratom for medical purposes because its safety and efficacy have not been verified
  • The agency cited animal and human studies linking Kratom to neurological harm, dependency, withdrawal symptoms and damage to the liver and kidneys
  • Forensic experts at the University Medical Center Hamburg-Eppendorf documented a March 2024 death solely attributed to Kratom poisoning
  • A joint expert commission is reviewing Kratom’s legal classification and several state authorities have begun imposing sales bans on products marketed with health claims
  • Kratom’s leaves contain mitragynine and 7-hydroxymitragynine alkaloids that produce opium-like effects despite centuries of traditional use in Southeast Asia